193 related articles for article (PubMed ID: 10960968)
1. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C
Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
4. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
[TBL] [Abstract][Full Text] [Related]
5. AgNOR pattern and PCNA analysis in fine needle biopsies of liver cell carcinoma.
Valenca JT; Escanhoel CA; Metze K
Neoplasma; 2001; 48(5):370-3. PubMed ID: 11845981
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
[TBL] [Abstract][Full Text] [Related]
7. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Anticancer Res; 1997; 17(2A):1155-62. PubMed ID: 9137464
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
9. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
10. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in liver tumors].
Wittekind C
Verh Dtsch Ges Pathol; 1995; 79():109-15. PubMed ID: 8600673
[TBL] [Abstract][Full Text] [Related]
13. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
Shimizu K; Izumi R; Ii T; Muraoka K; Inoue T; Fukushima W; Sakamoto K; Tani T; Hashimoto T; Yagi M
Hepatology; 1995 Feb; 21(2):393-7. PubMed ID: 7843711
[TBL] [Abstract][Full Text] [Related]
15. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
16. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
17. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
18. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
Ng IO; Ng M; Fan ST
Am J Gastroenterol; 1997 Aug; 92(8):1355-8. PubMed ID: 9260806
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N
J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
